Rapid Trial Bio (RTB) is an international startup company established in 2025 with the goal of connecting smaller early-stage funded biotech and pharmaceutical companies, starting in the European Union (EU) and North America, with niche and local contract research organizations (CROs) in the Asian region. These CROs offer competitive clinical phase pricing without compromising the quality and reliability provided by well-established multinational CROs.
The company's foundation stems from the founders' extensive connections with venture capitalists and investment groups, leveraging their experience as portfolio manager and business intelligence analyst. Additionally, their substantial network within the Asian CRO market played an important role in the development of the startup.
Company Details
- Employees
- 2
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Rapid Trial Bio Questions
Rapid Trial Bio's LinkedIn profile is https://www.linkedin.com/company/rapid-trial-bio
Rapid Trial Bio has
2 employees.
View email and phone details for 2
employees at Rapid Trial Bio.
Rapid Trial Bio's industry is
Biotechnology Research
Rapid Trial Bio's top competitors are
Palleos,
Cwm-Media,
Dcrm Sciences,
Rapidtrials,
Abbvie,
Sanofi,
Pharma Peak Research,
Biopharmiq By Amp,
Abbott,
Wcg.
Rapid Trial Bio's categories are Biotechnology Research
Rapid Trial Bio's founding year is 2025
